Skin analysis findings and disease severity in fibromyalgia patients

Basit Öğe Kaydı
dc.authoridTürkmen, Dursun/0000-0001-9076-4669
dc.authoridAkturk, SEMRA/0000-0001-9960-6851
dc.authorwosidTürkmen, Dursun/ABG-3801-2020
dc.authorwosidAkturk, SEMRA/KTH-9105-2024
dc.contributor.authorAkturk, Semra
dc.contributor.authorBuyukavci, Raikan
dc.contributor.authorAltunisik, Nihal
dc.contributor.authorTurkmen, Dursun
dc.contributor.authorTetik, Burcu Kayhan
dc.date.accessioned2024-08-04T21:01:09Z
dc.date.available2024-08-04T21:01:09Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: Fibromyalgia syndrome is a non-inflammatory disease characterized by widespread pain and various musculoskeletal symptoms. It can cause signs and symptoms in different systems of the body. Dermatological manifestations have not been fully clarified. Material and Methods: Participants were divided into two groups as patients and healthy controls. 25 people were included in each group. The disease severity of the patients and its impact on daily activities were evaluated with the Fibromyalgia Impact Questionnaire (FIQ) and Visual Analogue Scale (VAS). Skin analysis of both groups was performed with the API -100 Skin Analyzer. Erythema was assessed with the Clinician's Erythema Severity Index. Results: In this study %94 of the participants were women and %6 were men. The average age was 41.06 +/- 6.55. When the groups were compared, it was observed that the parameters determining skin quality were statistically significant in the control group than in the patient group. It was observed that fibromyalgia patients with skin erythema and sensitivity had higher VAS and FIQ scores than controls (p<0.05). Discussion: As a multisystemic disease, fibromyalgia is also likely to cause dermatologic symptoms. A multidisciplinary approach may be recommended in the treatment and follow-up of these patients.en_US
dc.description.sponsorshipInonu University Scientific Research Project Unit (Idot;nubap) [TSA-2022-2961]en_US
dc.description.sponsorshipThis study was supported by a research grant from the Inonu University Scientific Research Project Unit (& Idot;nubap) with the code TSA-2022-2961.en_US
dc.identifier.doi10.4328/ACAM.22011
dc.identifier.endpage111en_US
dc.identifier.issn2667-663X
dc.identifier.issue2en_US
dc.identifier.startpage108en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.22011
dc.identifier.urihttps://hdl.handle.net/11616/104136
dc.identifier.volume15en_US
dc.identifier.wosWOS:001157822900001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFibromyalgiaen_US
dc.subjectSkin Findingsen_US
dc.subjectPainen_US
dc.subjectQuality of Lifeen_US
dc.titleSkin analysis findings and disease severity in fibromyalgia patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu